Literature DB >> 18691436

Mosaic 22q11.2 microdeletion syndrome: diagnosis and clinical manifestations of two cases.

Ashutosh Halder1, Manish Jain, Madhulika Kabra, Neerja Gupta.   

Abstract

Chromosome 22q11.2 microdeletion syndrome is due to microdeletion of 22q11.2 region of chromosome 22. It is a common microdeletion syndrome however mosaic cases are very rare and reported only few previous occasions. In this report we describe two unrelated male children with clinical features consistent with 22q11.2 microdeletion syndrome characterized by cardiac defect, facial dysmorphism and developmental deficiency. One of the cases also had trigonocephaly. Interphase & metaphase FISH with 22q11.2 probe demonstrated mosaicism for hemizygous deletion of 22q11.2 region. Mosaicism is also observed in buccal cells as well as urine cells. Parents were without any deletion. These two cases represent rare cases of mosaic 22q11.2 microdeletion syndrome.

Entities:  

Year:  2008        PMID: 18691436      PMCID: PMC2527005          DOI: 10.1186/1755-8166-1-18

Source DB:  PubMed          Journal:  Mol Cytogenet        ISSN: 1755-8166            Impact factor:   2.009


Background

The 22q11.2 microdeletion syndrome is the most common microdeletion syndrome with an estimated incidence of one in 4000 births [1]. It has a wide phenotypic spectrum. Almost all cases result from a common deletion of chromosome 22q11.2 locus. Diagnosis of this microdeletion syndrome is based on prometaphase banding cytogenetics [2], fluorescent in situ hybridization (FISH) [3], array comparative genomic hybridization (aCGH) [4], quantitative fluorescent polymerase chain reaction (QFPCR) [5] with polymorphic micro satellite marker and multiplex ligation dependent probe amplification (MLPA) [6]. Interphase FISH is the prime method for diagnosis of mosaicism. Interphase FISH, being the only way to analyze large number of cells individually & quickly, has the ability to diagnose mosaicism including low level very easily and reliably. Diagnosis of 22q11.2 microdeletion mosaicism through FISH on amniocytes & cord blood cells [7], on peripheral blood lymphocytes [8,9] and on cardiac tissue [9] have been reported. In this report we describe two male children with clinical features of 22q11.2 microdeletion syndrome and FISH analysis showed mosaicism for a deletion in the critical region (22q11.2) in peripheral blood nucleated cells (both metaphase & interphase cells). Furthermore, one of the children had trigonocephaly (premature closure of metopic suture) in addition to features of 22q11.2 microdeletion syndrome despite low level of deleted cells. Trigonocephaly was reported only once in the literature [10]. We here report two rare cases of mosaic 22q11.2 microdeletion syndrome.

Case report

Case 1

A two years and ten months male child was referred from Fateyabad, Haryana, India to our hospital for cardiac malformation (tetralogy of Fallot) and facial dysmorphism. Pediatric geneticist referred the child to us to evaluate for 22q11.2 microdeletion syndrome. The child was born to a 23 year-old mother at 33 weeks 5 days by vaginal delivery in a local private hospital. He was 1400 gm at birth and was in nursery for first 20 days after birth. He was first born child of the couple. His record of length and head circumference was not available. There was no history of antenatal complications. Suckling was defective throughout infancy for which he was spoon fed until one year of age and never breast fed. He had recurrent episodes of upper respiratory infection including fever since infancy for which he was admitted several times in private hospital for the treatment. His milestone was delayed; unable to speak, walk or stand up even at age of 2 years ten months. He has no dyspnoea or cyanosis. There was no similar problem in the family excepting squint in mother and beta thalassaemia major in paternal side. Physical examination revealed dysmorphic features & generalized hypotonia. He had short & broad nose, small mouth, down turn upper lip, hypertelorism, telecanthus and squint (Fig. 1A). Ears were low set, deficient in vertical diameter and dysplastic. Palate was high arched. Hands & fingers were long and slender. His weight was 9 kg and height was 75.5 cm (both below 3rd percentile). Head circumference was 45 cm (below -2SD/below 2nd percentile), however proportionate to height & weight. His developmental quotient was between 41–45% of expected. Ophthalmologic examination was revealed squint. Extensive cardiovascular work up including echocardiography revealed mild pulmonary stenosis, large malaligned ventricular septal defect, dilated aortic root and was suggestive of tetralogy of Fallot. CT scan of head & brain was normal. There was no hypocalcemia. Conventional cytogenetics from lymphocyte culture was normal.
Figure 1

A is showing broad nose, square shaped tip of nose, small philtrum, hypertelorism, telecanthus, squint and low set ears. B is showing 22q11.2 FISH with deletion (most cells) and without deletion (arrow) on interphase cells obtained from peripheral blood.

A is showing broad nose, square shaped tip of nose, small philtrum, hypertelorism, telecanthus, squint and low set ears. B is showing 22q11.2 FISH with deletion (most cells) and without deletion (arrow) on interphase cells obtained from peripheral blood. Since the patient had findings strongly suggestive of 22q11.2 microdeletion syndrome FISH study to detect a possible deletion in the critical 22q11.2 region was done using PAC/BAC clones specific for 22q11.2 locus (RP5-882J5 & CTA-154H4 obtained from Uniba Biologia, Italy, by curtsy of Prof. M Rocchi). Interphase FISH was done using 1 ml of blood obtained from the patient. Blood nucleated cells washed in phosphate buffer saline solution three times before 30 minutes hypotonic treatment (50 mMol KCL) and fixation in methanol:acetic acid solution (3:1 ratio). Cells re-suspended in 100 ul fresh fixative. Approximately 20 ul cell suspension was used to prepare a slide. PAC/BAC clones were grown in LB broth, DNA extracted and about 1 ug DNA was labeled with green flurochrome (FITC) or red flurochrome (Cy3) by nick translation method. About 100 ng labeled probe was used for FISH. FISH analysis was carried out using Olympus BX51 microscope with epifluorescence attachment and image was captured through spectral imaging system. A total of 1312 interphase nuclei were scored. Interphase FISH result showed 1100 (83.8%) nuclei with hemizygous deletion for 22q11.2 locus and 210 (16%) nuclei with normal diploid state (Fig. 1B). Normal control cases displayed two signals in approximately 98% nuclei whereas positive controls displayed hemizygous deletion in approximately 98% nuclei. This finding was conclusive for mosaic 22q11.2 microdeletion with presence of low level of normal cells. FISH on metaphase spread pick up deletion in all excepting one of 25 metaphases studied. Interphase FISH was also carried out on buccal cells and urinary cells as described before [11] to find out whether mosaicism restricted to blood or generalized. Mosaicism was confirmed in all three types of cells (Table 1). Parents were also screened for deletion and results were negative.
Table 1

Details of FISH results of cases and their parents

ParametersOne Signal (%)Two Signals (%)Other Signals (%)Total CellsRemarks
Patient 1
Blood Interphase1100 (83.8)0210 (16)0002 (0.2)131216% normal cells
Blood Metaphase0024000100000025One normal cell (4%)
Buccal Cells0014 (77.8)0004 (22.2)0000001822.2% normal cells
Urinary Cells0008 (88.9)0001 (11.1)0000000911.1% normal cells
Mother's Blood (interphase)000001000000100Normal
Father's Blood (interphase)0001008100010083Normal
Patient 2
Blood Interphase121 (11.6)925 (88.4)000104688.4% normal cells
Blood Metaphase006 (15)034 (85)00004085% normal cells
Buccal Cells008 (13.8)050 (86.2)00005886.2% normal cells
Urinary Cells007 (14.6)041 (85.4)00004885.4% normal cells
Mother's Blood (metaphase)000030000030Normal
Father's Blood (metaphase)000020000020Normal
Details of FISH results of cases and their parents

Case 2

A one and half year old male child was referred from a village near Sirsa, Haryana, India to our hospital for cardiac malformation and facial dysmorphism. Pediatric geneticist referred the child to us to evaluate for 22q11.2 microdeletion syndrome. The child was born to a 27 year-old mother at term by vaginal delivery at local hospital. He was 1750 gm at birth. He was second born child of the non-consanguineous couple and his elder 3 years old sister was normal. His record of length and head circumference at birth was not available. There was no history of antenatal complications. However, early neonatal period was complicated by unconjugated hyperbillirubinemia that was managed by phototherapy. Suckling was normal however prone to have recurrent episode of vomiting in later part of infancy following intake of foods other than milk. His milestone was grossly delayed. He has significant dyspnoea since last six to seven months. There was no similar problem in the family in either side. Physical examination revealed dysmorphic features & generalized hypotonia. Most prominent feature was trigonocephaly with metopic prominence leading to forehead prominence. His head circumference was 45 cm (below -2 SD/below 2nd percentile). He had short & broad nose, small mouth, wide philtrum, thin upper lip, hypertelorism, telecanthus and upward slanting almond shaped eyes (Fig. 2A). Ears were low set. Ophthalmologic & auditory examination revealed no abnormality. He had central cyanosis and significant clubbing of fingers. Extensive cardiovascular work up including echocardiography was suggestive of tetralogy of Fallot with reversal of flow. An X ray skull and CT scan (Fig. 2B) of head & brain was consistent with craniosynostosis (due to premature metopic suture fusion). There was no hypocalcemia. Conventional cytogenetics from lymphocyte culture was normal.
Figure 2

A is showing broad & short nose, small moth, wide philtrum, thin upper lip, hypertelorism, telecanthus, upward slanting almond shaped eyes, low set ears and forehead prominence. B is CT scan of skull showing fusion of metopic suture. C is showing 22q11.2 FISH on lymphocytes (metaphase & interphase cells) without and with deletions (arrow).

A is showing broad & short nose, small moth, wide philtrum, thin upper lip, hypertelorism, telecanthus, upward slanting almond shaped eyes, low set ears and forehead prominence. B is CT scan of skull showing fusion of metopic suture. C is showing 22q11.2 FISH on lymphocytes (metaphase & interphase cells) without and with deletions (arrow). Since the patient had findings suggestive of 22q11.2 microdeletion syndrome FISH study was done using PAC/BAC clones specific for 22q11.2 locus (RP5-882J5 & CTA-154H4, obtained from Uniba Biologia, Italy, by curtsy of Prof. M Rocchi). A total of 1046 interphase nuclei were scored. Interphase FISH result showed 121 (11.6%) nuclei with hemizygous deletion for 22q11.2 locus and 925 (88.4%) nuclei with normal diploid state. About 15% metaphase also showed hemizygous deletion (Fig. 2C). Interphase FISH was also carried out on buccal cells and urinary cells to find out whether mosaicism restricted to blood or generalized. Mosaicism was confirmed in all three types of cells (Table 1). Parents were also screened for deletion and results were negative.

Discussion and conclusion

In this report we have presented two cases of mosaic 22q11.2 microdeletion syndrome. Both of our cases had tetralogy of Fallot along with facial dysmorphism despite low level of deleted cells (~15%) in case 2. Mosaicism in 22q11.2 microdeletion syndrome is rare and only a few cases [Table 2] have been described in literature [7-9,12] with variable manifestation viz. early death [8,9] to asymptomatic carrier parents [7,9]. Mosaic full monosomy of chromosome 22 that may present similar to 22q11.2 microdeletion syndrome is also rare [Table 2] and reported few occasions [13-17] with variable manifestation. Similarly, reports of mosaic 22q11.2 deletion with duplication also have been described in the literature on 2 occasions [Table 2; [18,19]]. Chen et al. (2004) [7] described a fetus with mosaicism for 22q11.2 hemizygous microdeletion (a ratio of 43 deleted: 57 normal) on amniocytes using FISH technique. The case had cardiac malformation typical of tetralogy of Fallot along with thymic hypoplasia. The father of fetus also had mosaic 22q11.2 microdeletion (a ratio of 19 deleted: 81 normal) however completely asymptomatic. Patel et al. (2006) [9] reported another case of mosaicism for 22q11.2 microdeletion in fetal cardiac tissue as well in maternal lymphocytes (10%) by FISH analysis. Similarly, Consevage et al 1996 [8] and Hatchwell et al 1998 [12] reported mosaic 22q11.2 microdeletion in lymphocytes and germ cells, respectively. Dempsey et al (2007) [18] and Blennow et al (2008) [19] reported two more cases of mosaicism. However, patients were mosaic for two abnormal cell lines instead of normal/abnormal cell lines: a deletion [del(22)(q11.2q11.2)] and duplication [dup(22)(q11.2q11.2)].
Table 2

Published reports on mosaic 22q11.2 microdeletion and mosaic monosomy 22

SNReferencesCase description in briefMethod usedResults
Mosaic 22q11.2 deletion
1Chen et al 2004 [7]Fetus with tetralogy of Fallot & thymic hypoplasiaFather asymptomaticInterphase FISH on amniocytesInterphase cells from cord bloodInterphase FISH on lymphocytes61% deleted interphase cells43% deleted interphase cells19% deleted interphase cells
2Consevage et al 1996 [8]Female newborn with facial dysmorphism, hypoplastic left heart syndrome & growth retardationMetaphase FISH in lymphocytes16% metaphases with deletion
3Patel et al 2006 [9]Missed abortion at 16 weeks gestationAsymptomatic carrier motherInterphase FISH on heart tissue LymphocytesCells with & without deletions10% deleted cells
4Hatchwell et al 1998 [12]Mother with 2 affected & one unaffected childFISH & haplotype analysisGerm line mosai-cism in mother
Mosaic monosomy 22
5Pinto-Escalante et al 1998 [13]Dysmorphism, joint contracture, scleroderma, hypertrichosis, hypertonicity, etcKaryotype from lymphocyte culture15% monosomic cells
6Verloes A et al 1987 [14]A child with mild facial dysmorphism and mentally deficiencyKaryotype on lymphocytes & fibroblast cells10.5% & 8.3% monosomic cells, respectively
7Sabui and Chakrobarty 1997 [15]Female child with facial dysmorphism & failure to thrive including developmental delayKaryotype on lymphocytes70% monosomic cells
8Lewinsky et al 1990 [16]Fetal gastroschisis with absent cerebral diastolic flowKaryotypeMosaic monosomy 22
9Moghe et al 1981 [17]Male child with facial dysmor-phism, psychomotor retardation, hypotonia & syndactylyKaryotype on lymphocytes25% monosomic cells
Mosaic 22q11.2 deletion & duplication
10Dempsey et al 2007 [18]Twin newborn, one normal & other with cardiac malformation as well as hypocalcemia, later delayed development and recurrent infectionsFISH on metaphase of lymphocytesFISH on metaphase of skin fibroblastsFISH on interphase skin fibroblast cellsDeletion in 55% cells; duplication in 45% cellsDeletion in 86% cells; duplication in 14% cells80% deleted cells
11Blennow et al. 2008 [19]Girl with dysmorphism but no cardiac malformationLymphocytesDeletion in 70% cells; duplication in 100% cells
Published reports on mosaic 22q11.2 microdeletion and mosaic monosomy 22 Due to variable manifestation from case to case or familial transmission with this syndrome many authors were looked for mosaicism, including tissue specific. However, outcome were contradictory; some had proven (cardiac tissue) [9] or disproven [5,20,21] while others suspected for gonadal mosaicism [22,23] with different laboratory approaches. Ideal laboratory approach to diagnose mosaicism should be interphase FISH as other method, including QF PCR/MLPA can not detect low level mosaicism due to the presence of a normal cell line, which would mask the appearance of deleted 22q11.2 region. Since interphase FISH analysis can assess large numbers of individual cells very quickly this technique can pick up even low level of mosaicism. Our second case emphasizes the importance of interphase FISH in the diagnosis of low level of mosaicism despite strong clinical manifestations. To establish a mosaicism, as we followed & confirmed (on metaphase as well as with another probe), a repeat blood sample should always be analyzed along with other tissues viz. buccal cells (ectodermal origin) &/or urine cells (endodermal origin). However, one should take precaution before diagnosing a mosaicism that hemizygous signal drop is frequent with interphase FISH (also influenced by type of tissue and probes) [24,25]. In our hand 22q11.2 locus specific probe (RP5-882J5 & CTA-154H4) provides hemizygous results in 1.76% interphase lymphocyte nuclei of normal individuals and we had taken care before diagnosing low level mosaicism (i.e., also confirmed by metaphase FISH & second adjacent probe at 22q11.21 locus i.e., CTA-154H4 BAC clone; metaphase FISH does not give rise to hemizygous deletion in normal controls). We also report on the association of trigonocephaly, one type of craniosynostosis, in one child with the mosaic 22q11.2 microdeletion. Yamamoto et al. (2006) [10] reported first time one patient with 22q11.2 microdeletion and craniosynostosis of the metopic suture leading to trigonocephaly. They suggested craniosynostosis of the metopic suture might be a minor complication, although coincidental occurrence cannot be ruled out. Here, we have encountered with another patient of 22q11.2 microdeletion (mosaic) with trigonocephaly derived from craniosynostosis of the metopic suture. This is the second report of a relationship between microdeletion 22q11.2 and trigonocephaly. Although trigonocephaly is rare with 22q11.2 microdeletion, it is commonly seen with monosomy 9p [26]. However, other form of craniosynostosis with 22q11.2 microdeletion syndrome is not so rare and reported in some previous occasions [27-31]. Ryan et al. (1997) [31] described five patients of microdeletion 22q11.2 syndrome with craniosynostosis without description of its type. McDonald-McGinn et al. (2005) [30] reported on the presence of craniosynostosis in another four patients with the 22q11.2 microdeletion syndrome. Similarly, De Silva et al. (1995), Karteszi et al. (2005), Dean et al. (1998), etc [27-29] reported some more cases of craniosynostosis in patient with microdeletion 22q11. In light of previous repeated reports of the association, we assume that craniosynostosis including trigonocephaly may be a rare manifestation of the 22q11.2 microdeletion syndrome. However, it seems that 12–15% mosaicism for 22q11.2 microdeletion may not solely account for the condition and the possibility of another undetected condition can not be ruled out. Craniosynostosis is also commonly seen with other chromosome deletions viz., with chromosome 15q (del(15)(q15q22.1) [32]; with chromosome 7p- [33-36] and 2q- [37]. Familial transmission of a 22q11.2 microdeletion accounts for 8 to 25% of the cases [38,39] and parents with deletions may be asymptomatic or mildly affected. However, none of the parents in our cases were carrier for the microdeletions. We conclude that mosaic 22q11.2 microdeletion is not very rare if investigated with interphase FISH, can present as severe phenotype even in the presence of low level of deleted cells and trigonocephaly/craniosynostosis may be a rare manifestation.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

AH formulated activity plan, checked results & interpretated results. He also had reviewed clinical findings, prepared manuscript and responded to the quarries of reviewers. He will be the guarantor of the manuscript. MJ carried out all FISH related activity under guidance of AH. MK and NG were involved in clinical suspicion of the disease and management of the cases. All authors read and approved final manuscript.

Consent

Written informed consent was obtained from the parent of patients for publication with any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal [vide additional files 1-2]

Additional File 1

Consent form 1. Click here for file

Additional File 2

Consent form 2. Click here for file
  37 in total

1.  22q11.2 deletion mosaicism in patients with conotruncal heart defects.

Authors:  Li Jianrong; Liu Yinglong; Lv Xiaodong; Yu Cuntao; Cui Bin; Wei Bo
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-04

Review 2.  Chromosomal variation in mammalian neuronal cells: known facts and attractive hypotheses.

Authors:  Ivan Y Iourov; Svetlana G Vorsanova; Yuri B Yurov
Journal:  Int Rev Cytol       Date:  2006

3.  Chromosome 7p--syndrome: craniosynostosis with preservation of region 7p2.

Authors:  D J Aughton; S B Cassidy; D A Whiteman; J A Delach; A E Guttmacher
Journal:  Am J Med Genet       Date:  1991-09-15

4.  22q11 microdeletion studies in the heart tissue of an abortus involving a familial form of congenital heart disease.

Authors:  Z M Patel; H M Gawde; M I Khatkhatay
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  Interstitial deletion of 22q11 in DiGeorge syndrome detected by high resolution and molecular analysis.

Authors:  U C Franke; P J Scambler; C Löffler; P Löns; F Hanefeld; B Zoll; I Hansmann
Journal:  Clin Genet       Date:  1994-08       Impact factor: 4.438

6.  Interstitial deletion of 2q associated with craniosynostosis, ocular coloboma, and limb abnormalities: cytogenetic and molecular investigation.

Authors:  J Nixon; M Oldridge; A O Wilkie; K Smith
Journal:  Am J Med Genet       Date:  1997-06-13

Review 7.  Full mosaic monosomy 22 in a child with DiGeorge syndrome facial appearance.

Authors:  D Pinto-Escalante; J M Ceballos-Quintal; I Castillo-Zapata; J Canto-Herrera
Journal:  Am J Med Genet       Date:  1998-03-05

8.  Mosaicism del(22)(q11.2q11.2)/dup(22)(q11.2q11.2) in a patient with features of 22q11.2 deletion syndrome.

Authors:  Melissa A Dempsey; Stuart Schwartz; Darrel J Waggoner
Journal:  Am J Med Genet A       Date:  2007-05-15       Impact factor: 2.802

9.  Concurrent microdeletion and duplication of 22q11.2.

Authors:  E Blennow; K Lagerstedt; H Malmgren; S Sahlén; J Schoumans; Bm Anderlid
Journal:  Clin Genet       Date:  2008-04-28       Impact factor: 4.438

10.  DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets.

Authors:  Kiran Kumar Mantripragada; Isabel Tapia-Páez; Elisabeth Blennow; Peter Nilsson; Anna Wedell; Jan P Dumanski
Journal:  Int J Mol Med       Date:  2004-02       Impact factor: 4.101

View more
  13 in total

1.  A case of 3q29 microdeletion syndrome involving oral cleft inherited from a nonaffected mosaic parent: molecular analysis and ethical implications.

Authors:  Aline L Petrin; Sandra Daack-Hirsch; Jamie L'Heureux; Jeffrey C Murray
Journal:  Cleft Palate Craniofac J       Date:  2010-05-04

2.  Human interphase chromosomes: a review of available molecular cytogenetic technologies.

Authors:  Svetlana G Vorsanova; Yuri B Yurov; Ivan Y Iourov
Journal:  Mol Cytogenet       Date:  2010-01-11       Impact factor: 2.009

Review 3.  Developmental trajectories in 22q11.2 deletion.

Authors:  Ann Swillen; Donna McDonald-McGinn
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-05-18       Impact factor: 3.908

4.  Cytogenetic, molecular-cytogenetic, and clinical-genealogical studies of the mothers of children with autism: a search for familial genetic markers for autistic disorders.

Authors:  S G Vorsanova; V Yu Voinova; I Yu Yurov; O S Kurinnaya; I A Demidova; Yu B Yurov
Journal:  Neurosci Behav Physiol       Date:  2010-09

5.  Prevalence of 22q11.2 microdeletion in 146 patients with cardiac malformation in a referral hospital of North India.

Authors:  Ashutosh Halder; Manish Jain; Isha Chaudhary; Madhulika Kabra
Journal:  BMC Med Genet       Date:  2010-06-23       Impact factor: 2.103

6.  Molecular screening for 22Q11.2 deletion syndrome in patients with congenital heart disease.

Authors:  Janaína Huber; Vivian Catarino Peres; Alexandre Luz de Castro; Tiago Jeronimo dos Santos; Lauro da Fontoura Beltrão; Angélica Cerveira de Baumont; Silvia Liliana Cossio; Tiago Pires Dalberto; Mariluce Riegel; Andrés Delgado Cañedo; Beatriz D'Agord Schaan; Lucia Campos Pellanda
Journal:  Pediatr Cardiol       Date:  2014-06-01       Impact factor: 1.655

7.  Combined 22q11.1-q11.21 deletion with 15q11.2-q13.3 duplication identified by array-CGH in a 6 years old boy.

Authors:  Emmanouil Manolakos; Catherine Sarri; Annalisa Vetro; Konstantinos Kefalas; Eleni Leze; Christalena Sofocleus; George Kitsos; Konstantina Merou; Haris Kokotas; Anna Papadopoulou; Achilleas Attilakos; Michael B Petersen; Sofia Kitsiou-Tzeli
Journal:  Mol Cytogenet       Date:  2011-02-23       Impact factor: 2.009

8.  Chromosome 22q11.2 microdeletion in monozygotic twins with discordant phenotype and deletion size.

Authors:  Ashutosh Halder; Manish Jain; Isha Chaudhary; Binuja Varma
Journal:  Mol Cytogenet       Date:  2012-03-13       Impact factor: 2.009

9.  Fluorescence in situ hybridization (FISH) using non-commercial probes in the diagnosis of clinically suspected microdeletion syndromes.

Authors:  Ashutosh Halder; Manish Jain; Isha Chaudhary; Neerja Gupta; Madhulika Kabra
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

10.  Chromosomal mosaicism goes global.

Authors:  Ivan Y Iourov; Svetlana G Vorsanova; Yuri B Yurov
Journal:  Mol Cytogenet       Date:  2008-11-25       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.